LSE:HLN (Haleon plc)
About HLN
Haleon (NYSE: HLN) is a leading global consumer health company with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories: Oral Health, Pain Relief, Respiratory Health, Digestive Health, Therapeutic Skin Health, and Wellness. Built on trusted science, innovation, and deep human understanding, Haleon's U.S. brands include Abreva, Advil, Benefiber, Centrum, Emergen-C, Excedrin, Flonase, Gas-X, Nexium, Nicorette, Parodontax, Polident, Preparation H, Pronamel, Sensodyne, Robitussin, Theraflu, TUMS, Voltaren, and more.
Haleon plc (LSE: HLN) Latest News
Investing Articles
2 FTSE 100 shares I’m steering clear of in today’s market
Investing Articles
£10,000 invested in Haleon shares 1 year ago is now worth…
Investing Articles
Is the FTSE 100 becoming increasingly disconnected from the UK economy?
Investing Articles
Looking for FTSE shares to buy? Here are 2 to consider for long-term gains
Investing Articles
Just released: the 3 best growth-focused stocks to consider buying in January [PREMIUM PICKS]
Investing Articles
The Haleon share price has woken up. Should I buy the FTSE 100 stock now?
Investing Articles
Haleon’s share price leaps 3% as first-half results reveal 11% profit increase. Is it time I buy?
Investing Articles
Here’s why the Haleon share price jumped 6% higher today
Investing Articles
Here are some of the best dividend forecasts I’ve seen for 2024
Investing Articles
The Haleon share price is stuck at £3! Should I invest?
Investing Articles
Should investors buy Haleon shares after the company raised its full-year guidance?